Klinische Wirksamkeit von Testogel^®

Isidori, A., et al. (2005, Sep). Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) , 63 (3), pp. 280-93.

Boloña, E., et al. (2007, Jan). Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc , 82 (1), pp. 20-8.

Corona, G., et al. (2014, Jun). Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med , 11 (6), pp. 1577-92.

Zarrouf, F., et al. (2009, Jul). Testosterone and depression: systematic review and metaanalysis. J Psychiatr Pract , 15 (4), pp. 289-305.

Tracz, M., et al. (2006, Jun). Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab , 91 (6), pp. 2011-6.

Snyder, P., et al (2016, Feb) Testosterone Trials Investigators. Effects of Testosterone Treatment in Older Men. N Engl J Med, 374(7), pp. 611-24.

Snyder PJ, Ellenberg SS, Cunningham GR, et al. (2014). The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clinical trials (London, England), 11(3),pp. 362-375.

Snyder PJ, Bhasin S., Cunningham GR, et al. (2018). Lessons from the Testosterone Trials. Endocrine reviews, 39(3), pp. 369-386.

Cunningham, G., et al. (2016, Aug). Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab , 101 (8), pp. 3096-104.

Snyder, P., et al. (2017, Apr). Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med, 177(4), pp. 471-9.

Roy, C., et al. (2017, Apr). Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern Med, 177(4), pp. 480-90.

Finkelstein JS, Lee H., Burnett-Bowie SA, et al. (2013). Gonadal steroids and body composition, strength, and sexual function in men. The New England journal of medicine, 369(11), pp.1011-1022.

Wang C., Swerdloff RS, Iranmanesh A., et al. (2000). Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab, 85(8), pp. 2839-2853.

Wang, C., et al. (2004, May). Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab, 89 (5), pp. 2085-98.